PLXS Raymond James Maintains Outperform April 2026

Raymond James maintained its Outperform rating on Plexus Corp. (PLXS) on April 30, 2026, signaling continued confidence in the electronics manufacturer. The analyst firm raised its price target significantly to $275 from $205, reflecting a 34% upside potential from current levels. This PLXS rating maintained action underscores strong fundamentals in the hardware and equipment sector. Plexus trades at $250.58 with a market cap of $6.7 billion, serving healthcare, aerospace, and industrial clients globally.

Raymond James Maintains Outperform on PLXS

Price Target Increase Signals Confidence

Raymond James raised its price target to $275 from $205, representing substantial upside from the current trading price of $250.58. This 34% increase in the price target reflects the analyst’s belief in Plexus’ growth trajectory and operational execution. The maintained Outperform rating indicates Raymond James expects PLXS to outperform the broader market over the next 12 months.

Analyst Consensus Remains Bullish

The broader analyst community supports this view, with 4 Buy ratings and no Sell or Hold recommendations in the consensus. This unanimous bullish stance reflects confidence in Plexus’ strategic positioning within the electronics manufacturing services sector. The PLXS rating maintained by Raymond James aligns with the overall market sentiment toward the company’s prospects.

Meyka AI Grades PLXS with B+ Rating

Comprehensive Financial Assessment

Meyka AI rates PLXS with a grade of B+, reflecting solid fundamentals and growth potential. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ rating suggests Plexus demonstrates above-average financial health relative to peers in the hardware and equipment sector.

Key Financial Metrics Support the Grade

Plexus shows strong operational metrics with a P/E ratio of 38.11, reflecting growth expectations. The company generated $161.06 in revenue per share and $7.01 in net income per share on a trailing twelve-month basis. Return on equity stands at 12.39%, indicating efficient capital deployment. These grades are not guaranteed and we are not financial advisors.

PLXS Stock Performance and Technical Setup

Recent Price Action and Momentum

Plexus stock trades near its 52-week high of $259.05, up significantly from the $115.35 low. Year-to-date performance shows 70.71% gains, demonstrating strong investor appetite. Technical indicators show RSI at 67.03, suggesting momentum without extreme overbought conditions. Volume remains elevated at 753,820 shares, well above the 360,301 average, indicating active institutional participation.

Growth Trajectory and Earnings Outlook

Net income growth accelerated 56.6% year-over-year, while EPS grew 56.1%, outpacing revenue growth of just 1.8%. This operational leverage demonstrates management’s ability to expand margins. Plexus reports earnings on July 22, 2026, providing the next catalyst for market reassessment. The company’s $6.7 billion market cap positions it as a significant player in electronics manufacturing services.

Why Raymond James Maintains Confidence in PLXS

Sector Tailwinds and Market Position

Plexus operates in the Hardware, Equipment & Parts industry within the Technology sector, benefiting from secular trends in healthcare, aerospace, and industrial automation. The company’s diversified customer base across multiple end markets reduces concentration risk. With 20,000 full-time employees globally, Plexus has the scale to capture growth opportunities across the Americas, Europe, and Asia-Pacific regions.

Financial Strength and Capital Allocation

The company maintains a current ratio of 1.59, indicating solid liquidity for operations and investments. Debt-to-equity stands at 0.15, reflecting conservative leverage. Free cash flow per share of $2.85 provides flexibility for shareholder returns and strategic investments. The PLXS rating maintained reflects confidence that these fundamentals will support continued outperformance.

Final Thoughts

Raymond James’ maintained Outperform rating and substantial price target increase to $275 underscore confidence in Plexus’ execution and market position. The PLXS rating maintained action, combined with unanimous analyst bullishness, reflects strong fundamentals and growth prospects. Plexus demonstrates operational leverage through accelerating earnings growth, solid balance sheet metrics, and exposure to secular growth trends. Meyka AI’s B+ grade aligns with this positive outlook. Investors should monitor the July earnings report for updates on margin expansion and customer wins. The maintained rating suggests Raymond James sees limited downside risk and meaningful upside potential from current levels.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.